Identifying viral vs bacterial infections is crucial – and Lumos is one ASX company helping make that call in minutes.

What’s in a name? When it comes to this 97-point Margaret River cabernet, the label stands for courage in the most trying of ...

Minnow Inhalerx hopes to be first to market with inhaled synthetic medical cannabis therapies for cancer pain and panic ...

Backed by government and industry partners, Micro-X is pushing its cold-cathode X-ray tech toward commercial readiness.

Zuleika reaches $48m settlement with Catalyst Metals and subsidiaries in long-running dispute over the Plutonic gold mine.

The ASX staged an info-tech fuelled recovery in the final hour, clawing back to neutral levels as losses in banking stocks ...

Cobre (ASX:CBE) secures a $4 million investment from Tribeca to support well-field development and exploration at the Ngami ...

Genetics Signatures says US sales of the company's Easyscreen diagnostics have disappointed, but a revamped strategy should ...

The ASX edged lower at lunch as oil rose on Black Sea strikes, miners slid and IperionX copped a sharp post-short seller ...

Adisyn (ASX:AI1) has passed another technical milestone, completing the initial phase of its low-temperature graphene ...

Strong patient demand and expanding trial sites are helping Paradigm progress its long-awaited phase III knee OA study.

Tylah Tully looks at Vertex Minerals and the increasingly alluring gold grades coming out of its Reward gold mine in New ...